The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-(2-(1H-indol-3-yl)ethyl)-6-chloro-N2-(7-methyl-1Hindazol-5-yl)quinazoline-2,4-diamine ID: ALA4095142
PubChem CID: 137655924
Max Phase: Preclinical
Molecular Formula: C26H22ClN7
Molecular Weight: 467.96
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Nc2nc(NCCc3c[nH]c4ccccc34)c3cc(Cl)ccc3n2)cc2cn[nH]c12
Standard InChI: InChI=1S/C26H22ClN7/c1-15-10-19(11-17-14-30-34-24(15)17)31-26-32-23-7-6-18(27)12-21(23)25(33-26)28-9-8-16-13-29-22-5-3-2-4-20(16)22/h2-7,10-14,29H,8-9H2,1H3,(H,30,34)(H2,28,31,32,33)
Standard InChI Key: KIBIXLNZTYVMJL-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
25.4512 -4.9609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4501 -5.7804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1581 -6.1894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1563 -4.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8649 -4.9573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8657 -5.7763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5742 -6.1834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2825 -5.7725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2778 -4.9504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5686 -4.5471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7434 -4.5525 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.5643 -3.7299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9918 -6.1784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.6979 -5.7670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4044 -6.1773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1100 -5.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6903 -4.9559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8544 -3.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8501 -2.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1402 -2.1030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0484 -1.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2481 -1.1282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3934 -2.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8484 -1.8378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0544 -2.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8043 -2.7823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3542 -3.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1462 -3.2132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3930 -4.5429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1069 -4.9484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7132 -4.3947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3739 -3.6470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5581 -3.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8192 -6.1727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 1 0
10 12 1 0
8 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 30 2 0
29 17 2 0
17 14 1 0
12 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 24 1 0
23 20 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 2 0
33 29 1 0
16 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 467.96Molecular Weight (Monoisotopic): 467.1625AlogP: 6.35#Rotatable Bonds: 6Polar Surface Area: 94.31Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.84CX Basic pKa: 3.90CX LogP: 6.16CX LogD: 6.16Aromatic Rings: 6Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.55
References 1. Hao C, Huang W, Li X, Guo J, Chen M, Yan Z, Wang K, Jiang X, Song S, Wang J, Zhao D, Li F, Cheng M.. (2017) Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy., 131 [PMID:28284095 ] [10.1016/j.ejmech.2017.02.063 ]